Search results
Peninsula biotech co-founded by Jennifer Doudna lands CRISPR gene-editing pact with Regeneron -...
The Business Journals· 7 days agoTrying to deliver compact CRISPR-based gene-editing packages to new places in the body, Regeneron...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via AOL· 7 days agoMammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to...
Can CRISPR-Cas gene editing tech fight antimicrobial resistance?
Investing.com· 4 days agoCan CRISPR-Cas gene editing tech fight antimicrobial resistance?
Experts develop way to harness CRISPR technology to deal with antimicrobial resistance
Phys.org· 5 days agoCRISPR-Cas gene-editing technology is a groundbreaking method in molecular biology that allows for...
Mammoth Biosciences to Receive $100M Upfront in Therapeutic CRISPR Gene Editing Deal With Regeneron
GenomeWeb News· 7 days agoAs part of the deal, Mammoth will receive a $95 million equity investment and a $5 million upfront payment from Regeneron at signing. Mammoth, cofounded by Jennifer
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Seeking Alpha· 7 days agoRegeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editing...
Researchers Discover Key Functions of Therapeutically Promising Jumbo Viruses
Newswise· 5 hours agoAntibiotic medicines became a popular treatment for bacterial infections in the early 20th century and emerged as a transformational tool in human health. Through the middle of the century novel ...
Regeneron and Mammoth Biosciences team up on gene editing By Investing.com
Investing.com· 7 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) and Mammoth Biosciences have announced a...
InnovationRx: FDA Approves Abbott’s Dissolvable Stents
Forbes· 1 day agoInnovationRx is your weekly digest of healthcare news. Severe cases of this disease can lead to strokes and heart attacks or to a condition called critical limb ischemia, which can have an extremely ...
Weekly AI Recap: Meta shares suffer, even as the company continues to ship new AI features
The Drum· 6 days agoInvestors got spooked, however, by Meta’s plans to push more money into AI R&D – an area which Meta has been expanding into rapidly but which is not yet profitable for the company. Meta chief ...